GIA
VRTX icon

GHP Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

GHP Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.6K Hold
168
– – ﹤0.01% 497
2026
Q1 		$75.2K Buy
168
+43
+34% +$20.1K ﹤0.01% 493
2025
Q4 		$56.8K Buy
125
+20
+19% +$8.62K ﹤0.01% 507
2025
Q3 		$41.3K Hold
105
– – ﹤0.01% 544
2025
Q2 		$46.9K Hold
105
– – ﹤0.01% 520
2025
Q1 		$51.1K Buy
105
+3
+3% +$1.4K ﹤0.01% 499
2024
Q4 		$41.1K Hold
102
– – ﹤0.01% 517
2024
Q3 		$47.4K Buy
102
+40
+65% +$19.2K ﹤0.01% 517
2024
Q2 		$29.1K Buy
+62
New +$26.9K ﹤0.01% 550
2023
Q4 		– Sell
-65
Closed -$24.1K – 950
2023
Q3 		$24.1K Hold
65
– – ﹤0.01% 582
2023
Q2 		$22.7K Hold
65
– – ﹤0.01% 574
2023
Q1 		$20.5K Buy
65
+23
+55% +$6.9K ﹤0.01% 583
2022
Q4 		$12.1K Hold
42
– – ﹤0.01% 651
2022
Q3 		$12K Hold
42
– – ﹤0.01% 648
2022
Q2 		$12K Buy
+42
New +$11.2K ﹤0.01% 654

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GHP Investment Advisors's VRTX Position: Q2 2026 in Review

GHP Investment Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 168 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

GHP Investment Advisors first reported a position in VRTX in Q2 2022 and has held it in 15 quarters since. 384 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • GHP Investment Advisors held 168 shares of Vertex Pharmaceuticals worth $83.6K as of Q2 2026.
  • GHP Investment Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #497 holding.
  • GHP Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • 384 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.